Average relative dose intensity and the impact on design of clinical trials.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008942:Mitoxantrone / Q000008:administration & dosage; D011379:Prognosis
D000970:Antineoplastic Agents; D004317:Doxorubicin; D008942:Mitoxantrone